Unknown

Dataset Information

0

Osmotic Tubulopathy in a Patient With COVID-19 Treated With Remdesivir.

ABSTRACT:

SUBMITTER: Wongboonsin J 

PROVIDER: S-EPMC8112887 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Osmotic Tubulopathy in a Patient With COVID-19 Treated With Remdesivir.

Wongboonsin Janewit J   Shah Sujal I SI   Marty Francisco M FM   Mount David B DB   Rennke Helmut G HG   Murakami Naoka N  

Kidney international reports 20210512 7

Similar Datasets

Unknown Risk factors for hyperglycemia in COVID-19 patients treated with remdesivir.
| S-EPMC10766056 | biostudies-literature
Unknown Clinical outcomes of remdesivir-treated COVID-19 patients in South Korea.
| S-EPMC9633264 | biostudies-literature
Unknown Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19.
| S-EPMC12304269 | biostudies-literature
Unknown Remdesivir and COVID-19.
| S-EPMC7529377 | biostudies-literature
Unknown Clinical outcomes of COVID-19 treated with remdesivir across the continuum of care.
| S-EPMC10205088 | biostudies-literature
Unknown Successful Desensitization to Remdesivir Hypersensitivity in a Patient Undergoing Treatment for COVID-19.
| S-EPMC10076168 | biostudies-literature
Unknown Elevated inflammatory markers are associated with poor outcomes in COVID-19 patients treated with remdesivir.
| S-EPMC8426873 | biostudies-literature
Unknown Remdesivir: A Review in COVID-19.
| S-EPMC10474216 | biostudies-literature
Unknown Remdesivir: From Ebola to COVID-19.
| S-EPMC7836944 | biostudies-literature
Unknown Clinical course of patients with severe COVID-19 pneumonia treated with remdesivir: A real-life study.
| S-EPMC9049514 | biostudies-literature